ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
A Redox-Active and Electroactive Hydrogel Enabled by an Integrated PEDOT@PMOF Nanofiller for Post-Infarct Myocardial Repair.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomaterial-assisted neuralization strategies for tissue engineering applications.Materials today. Bio · 2026Review
- A Redox-Active and Electroactive Hydrogel Enabled by an Integrated PEDOT@PMOF Nanofiller for Post-Infarct Myocardial Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Injury and apoptosis of cardiomyocytes (CMs) lead to the excessive accumulation of reactive oxygen species (ROS) within the infarcted region, which affects the viability of healthy CMs in the border zone and contributes to the progressive enlargement of the infarct area. The subsequent replacement of necrotic myocardium with fibrotic tissue disrupts normal electrophysiological conduction pathways. This study develops a multifunctional hydrogel, TAlg/PEDOT@PMOF, incorporating an integrated PEDOT@PMOF nanofiller designed to simultaneously scavenge ROS and restore electrical coupling following myocardial infarction (MI). The ROS-neutralizing capability of the nanofiller stems from the manganese porphyrin, which closely emulates the catalytically active site of native antioxidant enzymes. To increase electrical conductivity, the conductive polymer PEDOT is immobilized onto the MOF structure via a polydopamine (PDA) adhesion layer. Furthermore, the hydrogel network is functionalized with cell-adhesion peptides, enabling a synergistic enhancement of ROS clearance and electrical signal transmission by the nanofiller at both the cellular and tissue scales. This dual functionality is evidenced by improved cytoprotection under oxidative stress, enhanced calcium transient in cardiomyocytes, restoration of cardiac function, and reduced susceptibility to arrhythmia. These results establish an effective strategy for engineering an integrated enzyme-mimicking system and highlight a practical and innovative approach for future MI therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.